loader image

News

Avricore Health Inc To Webcast Live at Life Sciences Investor Forum June 24th

Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) based in Vancouver, Canada focused on networked point-of-care testing in pharmacies technology HealthTab™ today announced that CEO, Hector Bremner will present live at LifeSciencesInvestorForum.com on June 24 th . DATE: Thursday, June 24 th TIME: 11:00am PT / 2:00pm ET LINK: https://bit.ly/3c7Ertp

Read More

Avricore Health Corporate Update Summer 2021

VANCOUVER, BRITISH COLUMBIA – June 9, 2021) – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) is pleased to provide this corporate update on the Company’s successes in 2021, which have included securing significant financing and key commercial agreements, putting it on track for its most successful year to

Read More

Avricore Health Signs Master Agreement To Pilot HealthTab™ Platform for Diabetes Management in Select Shoppers Drug Mart® Pharmacies

VANCOUVER, BC – (GLOBE NEWSWIRE) – June 3, 2021 – Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce patients will soon have access to its innovative point-of-care blood screening and health-data management platform, HealthTab™, at select Shoppers Drug Mart locations. Through this pilot program, patients will have greater

Read More

Avricore Health’s HealthTab™ Signs Distribution Agreement To Expand Pharmacy Network and Test Offering

VANCOUVER, BC – (GLOBE NEWSWIRE) – May 31, 2021 – Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of a supplier distribution agreement between HealthTab™ Inc., a wholly owned subsidiary, and Abbott, the global healthcare company and diagnostics leader, in Canada. This agreement allows the Company

Read More

Avricore Health Partners With Avrok Laboratories To Offer Real-Time COVID-19 Screening for Travelers

Utilizing HealthTab™ and rapid-antigen tests at resort locations to screen for the virus prior to return, with validation from Avrok Laboratories, US travellers can return home with peace of mind.  VANCOUVER, BC – (GLOBE NEWSWIRE) – February 16, 2021 – Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce

Read More

Avricore Health Completes $1.54 Million Financing

VANCOUVER, BRITISH COLUMBIA – February 9, 2021 – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) announces it has closed its non-brokered private placement announced on February 3rd for gross proceeds of $1,540,000. The Company will issue 7,000,000 units at $0.22 per unit and will pay finders fees totaling

Read More

Whole Health Pharmacy Partners To Launch Avricore’s HealthTab™

VANCOUVER, BC – (GLOBE NEWSWIRE) – February 9, 2021 – Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce it will be placing its real-time reporting HealthTabÔ systems in Whole Health Pharmacy Partner locations. “We’ve been excited by the amount of interest and support building for HealthTab™,” said Avricore

Read More

Avricore Health Announces $1.54 Million Financing

VANCOUVER, BRITISH COLUMBIA – February 3, 2021 – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) announces a non-brokered private placement of up to 7,000,000 units (“Units“) at a price of $0.22 per unit for gross proceeds of $1,540,000. (the “Private Placement“). The proceeds will be used for general

Read More

Avricore Health Completes $1.5 Million Financing

VANCOUVER, BRITISH COLUMBIA – January 26, 2021 – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) announces it has closed the final tranche of its non-brokered private placement for gross proceeds of $874,000 to complete its $1.5 million financing. The Company will issue 8,740,000 units at $0.10 per unit

Read More